Name: Mathematics Problem Solving and Professional Development Under the COVID-19 Pandemic
Start: 2020-12-10T19:00:00-05:00
End: 2020-12-10T20:00:00-05:00

Tetracycline-based Antibiotics Show Promise for Combating Zika Infections

Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine

Pfizer and BioNTech Submit COVID-19 Vaccine for Emergency Use Approval in U.S.

by Global Biodefense Staff November 20, 2020, 8:37 am
Lawmakers Press HSS for Information on Remdesivir Pricing Negotiations with Gilead

by Global Biodefense Staff November 19, 2020, 10:28 am
NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

by Global Biodefense Staff November 18, 2020, 3:18 pm
DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

by Global Biodefense Staff October 31, 2020, 2:40 pm
Regeneron Halts Trial for Antibody Cocktail in Sickest COVID-19 Patients

by Global Biodefense Staff October 30, 2020, 1:05 pm
New Study Casts Doubt on Benefit of Tocilizumab for Worsening Cases of COVID-19

by Global Biodefense Staff October 24, 2020, 3:35 pm
Targeting the Shell of the Ebola Virus for a Knock-Out with Antivirals

by Global Biodefense Staff October 24, 2020, 2:10 pm
Hydroxychloroquine as Pre-Exposure Prophylaxis: Randomized Clinical Trial Shows No Benefit

by Global Biodefense Staff October 23, 2020, 3:07 pm
Building an ACE2 Receptor Trap for Pandemic Pathogens

by Global Biodefense Staff October 23, 2020, 11:12 am
BARDA Awards Medical Countermeasures Clinical Studies Network Contracts

by Global Biodefense Staff October 20, 2020, 1:40 pm
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
Finding the Golden Window for Collecting COVID-19 Survivor Antibodies

by Global Biodefense Staff October 19, 2020, 4:26 pm
FDA Approves First Ebola Therapeutic

by Global Biodefense Staff October 15, 2020, 6:49 pm
Until a Coronavirus Vaccine is Ready, Pneumonia Vaccines May Reduce Deaths from COVID-19

by Robert Root-Bernstein, Michigan State University October 15, 2020, 6:37 pm
SARS, MERS, COVID-19: Repurposing Drugs for a Pan-Coronavirus Treatment

by Global Biodefense Staff October 15, 2020, 12:04 pm

Congratulations. You've reached the end of the internet.

Medical Countermeasures

Tetracycline-based Antibiotics Show Promise for Combating Zika Infections

Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine

Pfizer and BioNTech Submit COVID-19 Vaccine for Emergency Use Approval in U.S.

Lawmakers Press HSS for Information on Remdesivir Pricing Negotiations with Gilead

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Regeneron Halts Trial for Antibody Cocktail in Sickest COVID-19 Patients

New Study Casts Doubt on Benefit of Tocilizumab for Worsening Cases of COVID-19

Targeting the Shell of the Ebola Virus for a Knock-Out with Antivirals

Hydroxychloroquine as Pre-Exposure Prophylaxis: Randomized Clinical Trial Shows No Benefit

Building an ACE2 Receptor Trap for Pandemic Pathogens

BARDA Awards Medical Countermeasures Clinical Studies Network Contracts

Finding the Golden Window for Collecting COVID-19 Survivor Antibodies

FDA Approves First Ebola Therapeutic

Until a Coronavirus Vaccine is Ready, Pneumonia Vaccines May Reduce Deaths from COVID-19

SARS, MERS, COVID-19: Repurposing Drugs for a Pan-Coronavirus Treatment

Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine

Testing Sewage Can Give Schools and Businesses a Heads-Up on the Spread of COVID-19

Pfizer and BioNTech Submit COVID-19 Vaccine for Emergency Use Approval in U.S.

Lawmakers Press HSS for Information on Remdesivir Pricing Negotiations with Gilead

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

Naval Research Lab Evaluates Ultraviolet Sources Against SARS-CoV-2

Meet Ruby the Supercomputer: Now in Service for COVID-19 and Nuclear Security Research

Originally Built for Bioterrorism Agents, This Decontamination System Now Clears SARS-CoV-2 from Military Aircraft

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

State Department: Reducing Revisionist State Biological and Chemical Weapons Threats

BARDA Awards Medical Countermeasures Clinical Studies Network Contracts

W. Virginia CBRN Response Enterprise Assists with COVID-19 Testing Innovation Roll Out

Latest Articles

Medical Countermeasures News